Page 769 - medicina-integrativa_compress

784 PARTE II, SECCIÓN 12 DERMATOLOGÍA

25. Murray MT, Pizzorno JE: Rosacea. In Murray MT, Pizzorno JE 44. A randomized, placebo-controlled, clinical trial of high-dose
(eds): Textbook of Natural Medicine, 2nd ed, vol 2. New York, supplementation with vitamins C and E, beta carotene, and zinc for
Churchill Livingstone, 1999. age-related macular degeneration and vision loss: AREDS report no. 8.
26. Wilkin J, Dahl M, Detmar M, et al: Standard classification of Arch Ophthalmol 119:1417-1436, 2001.
rosacea: Report of the National Rosacea Society Expert Committee 45. The effect of five-year zinc supplementation on serum zinc, serum
on the Classification and Staging of Rosacea. J Am Acad Dermatol cholesterol and hematocrit in persons randomly assigned to
46:584-587, 2002. treatment group in the age-related eye disease study: AREDS Report
27. Toombs EL: Cosmetics in the treatment of acne vulgaris. Dermatol No. 7. J Nutr 132:697-702, 2002.
Clin 23:575-581, 2005. 46. Bassett IB, Pannowitz DL, Barnetson RS: A comparative study of
28. Pelle MT, Crawford GH, James WD: Rosacea. II: Therapy. J Am tea-tree oil versus benzoylperoxide in the treatment of acne.
Acad Dermatol 51:499-512; quiz 513-514, 2004. Med J Aust 153:455-458, 1990.
29. Blount BW, Pelletier AL: Rosacea: A common, yet commonly 47. Ernst E, Huntley A: Tea tree oil: A systematic review of randomized
overlooked, condition. Am Fam Physician 66:435-440, 2002. clinical trials. Forsch Komplementarmed Klass Naturheilkd 7:17-20,
30. Jansen T, Romiti R, Kreuter A, Altmeyer P: Rosacea fulminans 2000.
triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol 48. Martin KW, Ernst E: Herbal medicines for treatment of bacterial
Venereol 15:484-485, 2001. infections: A review of controlled clinical trials. J Antimicrob
31. Logan AC: Omega-3 fatty acids and acne. Arch Dermatol 139: Chemother 51:241-246, 2003.
941-942; author reply 942-943, 2003. 49. Krowchuk DP: Managing acne in adolescents. Pediatr Clin North
32. Berbis P, Hesse S, Privat Y: [Essential fatty acids and the skin] Allerg Am 47:841-857, 2000.
Immunol (Paris) 22:225-231, 1990. 50. Nguyen QH, Bui TP: Azelaic acid: Pharmacokinetic and
33. Magin P, Pond D, Smith W, Watson A: A systematic review of the pharmacodynamic properties and its therapeutic role in
evidence for ‘myths and misconceptions’ in acne management: hyperpigmentary disorders and acne. Int J Dermatol 34:75-84, 1995.
Diet, face-washing and sunlight. Fam Pract 22:62-70, 2005. 51. Feldman S, Careccia RE, Barham KL, Hancox J: Diagnosis and
34. Blumenthal M, Goldberg A, Brinckmann J: Yeast. In Blumenthal M, treatment of acne. Am Fam Physician 69:2123-2130, 2004.
Goldberg A, Brinckmann J (eds): Herbal Medicine: Expanded 52. Haider A, Shaw JC: Treatment of acne vulgaris. JAMA 292:726-735,
German Commission E Monographs. Newton, Mass.: Integrative 2004.
Medicine Communications, 2000. 53. Jick SS, Kremers HM, Vasilakis-Scaramozza C: Isotretinoin use and
35. Weber G, Adamczyk A, Freytag S: Treatment of acne with a yeast risk of depression, psychotic symptoms, suicide, and attempted
preparation. Fortschr Med 107:563-566, 1989. suicide. Arch Dermatol 136:1231-1236, 2000.
36. Brewer’s yeast. In Jellin JM (ed): Natural Medicines comprehensive 54. Johnson BA, Nunley JR: Use of systemic agents in the treatment of
Database, 4th ed. Stockton, Calif, Therapeutic Research Faculty, acne vulgaris. Am Fam Physician 62:1823-1830, 2000.
2002. 55. Kocak M, Yagli S, Vahapoglu G, Eksioglu M: Permethrin 5% cream
37. Michaelsson G, Juhlin L, Vahlquist A: Effects of oral zinc and versus metronidazole 0.75% gel for the treatment of papulopustular
vitamin A in acne. Arch Dermatol 113:31-36, 1977. rosacea: A randomized double-blind placebo-controlled study.
38. Michaelsson G, Juhlin L, Ljunghall K: A double-blind study of the Dermatology 205:265-270, 2002.
effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 56. Akamatsu H, Asada Y, Horio T: Effect of keigai-rengyo-to, a Japanese
97:561-566, 1977. kampo medicine, on neutrophil functions: A possible mechanism of
39. Dreno B, Moyse D, Alirezai M, et al: Multicenter randomized action of keigai-rengyo-to in acne. J Int Med Res 25:255-265, 1997.
comparative double-blind controlled clinical trial of the safety 57. Higaki S, Morimatsu S, Morohashi M, et al: Susceptibility of
and efficacy of zinc gluconate versus minocycline hydrochloride Propionibacterium acnes, Staphylococcus aureus and Staphylococcus
in the treatment of inflammatory acne vulgaris. Dermatology epidermidis to 10 Kampo formulations. J Int Med Res 25:318-324, 1997.
203:135-140, 2001. 58. Thappa DM, Dogra J: Nodulocystic acne: Oral gugulipid versus
40. Dreno B, Amblard P, Agache P, et al: Low doses of zinc gluconate tetracycline. J Dermatol 21:729-731, 1994.
for inflammatory acne. Acta Derm Venereol 69:541-543, 1989. 59. Paranjpe P, Kulkarni PH: Comparative efficacy of four Ayurvedic
41. Dreno B, Foulc P, Reynaud A, et al: Effect of zinc gluconate on formulations in the treatment of acne vulgaris: A double-blind
Propionibacterium acnes resistance to erythromycin in patients randomised placebo-controlled clinical evaluation.
with inflammatory acne: In vitro and in vivo study. Eur J Dermatol J Ethnopharmacol 49:127-132, 1995.
15:152-155, 2005. 60. Hughes H, Brown BW, Lawlis GF, Fulton JE Jr: Treatment of acne
42. Salzman MB, Smith EM, Koo C: Excessive oral zinc vulgaris by biofeedback relaxation and cognitive imagery.
supplementation. J Pediatr Hematol Oncol 24:582-584, 2002. J Psychosom Res 27:185-191, 1983.
43. Irving JA, Mattman A, Lockitch G, et al: Element of caution: A case 61. Georgala S, Schulpis KH, Georgala C, Michas T: L-Carnitine
of reversible cytopenias associated with excessive zinc supplementation in patients with cystic acne on isotretinoin
supplementation. CMAJ 169:129-131, 2003. therapy. J Eur Acad Dermatol Venereol 13:205-209, 1999.